One-step synthesis of site-specific antibody-drug conjugates by reprograming IgG glycoengineering with LacNAc-based substrates
Glycosite-specific antibody‒drug conjugatess (gsADCs), harnessing Asn297 N-glycan of IgG Fc as the conjugation site for drug payloads, usually require multi-step glycoengineering with two or more enzymes, which limits the substrate diversification and complicates the preparation process. Herein, we...
Saved in:
Main Authors: | Wei Shi (Author), Wanzhen Li (Author), Jianxin Zhang (Author), Tiehai Li (Author), Yakai Song (Author), Yue Zeng (Author), Qian Dong (Author), Zeng Lin (Author), Likun Gong (Author), Shuquan Fan (Author), Feng Tang (Author), Wei Huang (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2022-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Latest Advances in Glycoengineering
Published: (2020) -
A versatile design platform for glycoengineering therapeutic antibodies
by: Seth D. Ludwig, et al.
Published: (2022) -
The evaluation of IgG4 and IgG expression in cutaneous Rosai-Dorfman disease
by: Puyu Zou, et al.
Published: (2023) -
Metabolic Glycoengineering: A Promising Strategy to Remodel Microenvironments for Regenerative Therapy
by: Yi Li, et al.
Published: (2023) -
Report of Two Cases of Pediatric IgG4-Related Lymphadenopathy (IgG4-LAD): IgG4-Related Disease (IgG4-RD) or a Distinct Clinical Pathological Entity?
by: Mariaclaudia Meli, et al.
Published: (2022)